Ticker
SCYXCompany Name
SCYNEXIS INCSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NASDAQDate | Total Assets | Total Debt | Debt to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 60.69M | $ 2.39M | 3.94% |
3/31/2025 | $ 67.92M | $ 2.49M | 3.66% |
12/31/2024 | $ 90.64M | $ 16.27M | 17.95% |
9/30/2024 | $ 99.04M | $ 15.9M | 16.05% |
6/30/2024 | $ 107.81M | $ 15.54M | 14.42% |
3/31/2024 | $ 118.25M | $ 15.23M | 12.88% |
12/31/2023 | $ 128.41M | $ 15.08M | 11.74% |
9/30/2023 | $ 148.55M | $ 14.81M | 9.97% |
6/30/2023 | $ 154.86M | $ 14.7M | 9.49% |
3/31/2023 | $ 70.3M | $ 49.19M | 69.98% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Debt / Assets
(=) Debt to Assets
Debt to Assets for SCYNEXIS INC is calculated as follows: Debt [ $ 16.65M ] / Assets [ $ 36.75M ]
(=) Debt to Assets [ 45.31% ]
Minimum
Mar 31, 2025
Maximum
Mar 31, 2023
Average
Median
filtered constituents | 4.38K |
---|---|
min | 0% |
max | 116.6% |
average | 26.34% |
median | 21.09% |
std | 24.52% |